131 related articles for article (PubMed ID: 6858823)
1. Agranulocytosis due to new sustained-release procainamide.
Berger BE; Hauser DJ
Am Heart J; 1983 Jun; 105(6):1035-6. PubMed ID: 6858823
[No Abstract] [Full Text] [Related]
2. Severe neutropenia due to sustained-release procainamide.
Hoyt RE
South Med J; 1987 Sep; 80(9):1196-7. PubMed ID: 3629327
[TBL] [Abstract][Full Text] [Related]
3. Procainamide-induced agranulocytosis.
Reidy TJ; Upshaw JD
South Med J; 1984 Dec; 77(12):1582-4. PubMed ID: 6505768
[TBL] [Abstract][Full Text] [Related]
4. Severe neutropenia associated with procainamide: comparison of sustained release and conventional preparations.
Meyers DG; Gonzalez ER; Peters LL; Davis RB; Feagler JR; Egan JD; Nair CK
Am Heart J; 1985 Jun; 109(6):1393-5. PubMed ID: 4003250
[No Abstract] [Full Text] [Related]
5. Agranulocytosis secondary to extended-release procainamide: a case report and review of the literature. A case of agranulocytosis caused by procainamide in a patient who had undergone open-heart surgery.
Malters PB; Salem AG
S D J Med; 1987 Feb; 40(2):7-10. PubMed ID: 3470941
[No Abstract] [Full Text] [Related]
6. Agranulocytosis in a 12-year-old girl treated with procainamide.
Gunay U; Honig GR
Clin Pediatr (Phila); 1974 Sep; 13(9):728-30. PubMed ID: 4411903
[No Abstract] [Full Text] [Related]
7. Agranulocytosis associated with procainamide therapy--report of a case.
Prince RA; Brown BT; Jacknowitz AI
Am J Hosp Pharm; 1977 Dec; 34(12):1362-5. PubMed ID: 596390
[TBL] [Abstract][Full Text] [Related]
8. Desensitization to procainamide.
Ream CR; Barrera R
J Med Soc N J; 1970 Mar; 67(3):107-10. PubMed ID: 5264623
[No Abstract] [Full Text] [Related]
9. Plasma levels of procaine amide after administration of conventional and sustained-release tablets.
Karlsson E
Eur J Clin Pharmacol; 1973 Dec; 6(4):245-50. PubMed ID: 4591151
[No Abstract] [Full Text] [Related]
10. Sustained-release procainamide-induced reversible granulocytopenia after myocardial infarction.
Abe H; Suzuka H; Tasaki H; Kuroiwa A
Jpn Heart J; 1995 Jul; 36(4):483-7. PubMed ID: 7474364
[TBL] [Abstract][Full Text] [Related]
11. Experiences on a sustained-release procainamide preparation.
Ruosteenoja R; Torsti P; Sothmann A
Curr Ther Res Clin Exp; 1973 Oct; 15(10):707-12. PubMed ID: 4201315
[No Abstract] [Full Text] [Related]
12. A new sustained-release tablet formulation of procainamide.
Fremstad D; Dahl S; Jacobsen S; Lunde PK; Nådland KJ; Marthinsen AA; Waaler T; Landmark KH
Eur J Clin Pharmacol; 1973 Dec; 6(4):251-5. PubMed ID: 4591152
[No Abstract] [Full Text] [Related]
13. Efficacy of a new sustained release procainamide preparation: evaluation with 24-hour Holter monitoring.
Garcia JR; Godley ML; Freedman RJ
J La State Med Soc; 1982; 134(1):8-9. PubMed ID: 7086265
[No Abstract] [Full Text] [Related]
14. Sustained-release procainamide and neutropenia.
Anderson S; Wenger NK
Ann Intern Med; 1984 Sep; 101(3):404. PubMed ID: 6465719
[No Abstract] [Full Text] [Related]
15. Conventional and sustained-release procainamide: update on pharmacology and clinical use.
Anderson JL
Clin Ther; 1985; 7(5):618-40. PubMed ID: 3902240
[TBL] [Abstract][Full Text] [Related]
16. [Serum concentrations of procainamide during treatment with ordinary and sustained-release tablets].
Henningsen P; Laursen HB; Christiansen BD; Moller J
Ugeskr Laeger; 1976 Sep; 138(40):2433-7. PubMed ID: 968997
[No Abstract] [Full Text] [Related]
17. Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets.
Arstila M; Katila M; Sundquist H; Anttila M; Pere E; Tikkanen R
Acta Med Scand; 1974 Mar; 195(3):217-22. PubMed ID: 4595254
[No Abstract] [Full Text] [Related]
18. Agranulocytosis during combined procainamide and phenytoin therapy.
Crook JE; Woosley RL; Leftwich RB; Natelson EA
South Med J; 1979 Dec; 72(12):1599-601. PubMed ID: 515773
[TBL] [Abstract][Full Text] [Related]
19. Agranulocytosis, thrombocytopenia, and procainamide.
Christensen DJ; Palma LF; Phelps K
Ann Intern Med; 1984 Jun; 100(6):918. PubMed ID: 6721310
[No Abstract] [Full Text] [Related]
20. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].
Bliddal J
Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996
[No Abstract] [Full Text] [Related]
[Next] [New Search]
